Home / Health / Mice Live Longer on Weight Loss Drugs: New Study
Mice Live Longer on Weight Loss Drugs: New Study
5 Sep
Summary
- Semaglutide drugs extended mouse lifespan by approximately 12%.
- Drugs improved blood sugar, appearance, behavior, and memory in mice.
- GLP-1s may work independently of calorie restriction, study suggests.
Recent research using mice indicates that weight loss medications, such as those containing semaglutide, might contribute to a longer lifespan. The study observed that these GLP-1 drugs extended the mice's lives by approximately 12%, adding around 100 days to their normal lifespan.
Beyond longevity, the medications notably improved the mice's blood sugar regulation, physical appearance, and behavior. A separate experiment further suggested that these health benefits are not solely due to reduced food intake, as mice on the drugs showed greater improvements than those on a restricted diet.
This distinction points towards GLP-1 drugs potentially influencing biological pathways separate from calorie restriction. While these findings are from animal studies, they offer promising insights for future human trials exploring the anti-aging potential and broader clinical benefits of these widely used medications.
GLP-1s, currently approved for weight loss and diabetes, are seeing expanded use. For instance, Eli Lilly's Mounjaro recently gained FDA approval to lower cardiovascular event risk in Type 2 diabetes patients, highlighting the evolving applications of these drugs.
